前列腺癌幸存者的心血管预防保健与照护协调:一项多机构前瞻性研究
该多机构前瞻性研究纳入103例接受雄激素剥夺治疗(ADT)联合放疗的前列腺癌患者,评估基线与放疗后1年心血管危险因素及生存照护。基线心血管疾病患病率39%,危险因素普遍;放疗后1年63%接受符合美国心脏协会指南的心血管监测,患者对照护协调感知较低,作者认为需开展临床试验改善照护与结局。
要点
- 接受ADT联合放疗的前列腺癌患者基线心血管疾病(39%)及糖尿病(22%)、高血压(63%)、高脂血症(31%)普遍。
- 放疗完成后第1年,63%患者接受符合美国心脏协会指南的心血管监测。
- 1年时24%血糖控制不充分、22%胆固醇升高;患者对照护协调感知相对较低。
核心结论
- 接受ADT和放疗的前列腺癌患者是基线心血管疾病及危险因素普遍且生存照护(特别是照护协调与心血管监测)欠佳的脆弱人群,需要开展临床试验研究改善这些幸存者照护与结局的方法。
研究设计与样本
- 多机构前瞻性研究,从7家机构前瞻性入组103例接受ADT联合放疗的前列腺癌男性,评估心血管危险因素与生存照护。
- 在基线(治疗前)和放疗后1年评估病历、空腹实验室检查值及采用经验证工具的患者报告结局。
主要发现
- 基线时心血管疾病患病率39%,糖尿病22%,高血压63%,高脂血症31%。
- 放疗完成后第1年,63%患者接受符合美国心脏协会指南的心血管监测。
- 1年时空腹实验室检查显示24%血糖控制不充分、22%胆固醇升高。
- 1年时57%报告其初级保健医生「总是知道我于其他场所接受的照护」,67%报告其肿瘤医生「与我就诊的其他提供者沟通过」,65%报告肿瘤照护医生「知道我于其他医生处就诊的结果」。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Prostate cancer survivors who receive androgen deprivation therapy (ADT) are at increased risk of cardiovascular disease. They require coordinated care between cancer specialists and primary care physicians to monitor for cancer control and manage cardiovascular risk factors. METHODS AND MATERIALS: We prospectively enrolled 103 men receiving ADT with radiation therapy (RT) from 7 institutions to assess cardiovascular risk factors and survivorship care. Medical records, fasting laboratory test values, and patient-reported outcomes using a validated instrument were assessed at baseline (pretreatment) and 1 year post-RT. RESULTS: Cardiovascular disease (39%) and risk factors (diabetes, 22%; hypertension, 63%; hyperlipidemia, 31%) were prevalent at baseline. During the first year after RT completion, 63% received cardiovascular monitoring concordant with American Heart Association guidelines. Fasting laboratory test values at 1 year showed 24% with inadequately controlled blood sugar and 22% elevated cholesterol. Patient perceptions about care coordination were relatively low. At 1 year, 57% reported that their primary care physicians "always know about the care I receive at other places," 67% reported that their cancer physician "communicated with other providers I see," and 65% reported that the cancer care physician "knows the results of my visits with other doctors." CONCLUSIONS: Patients with prostate cancer who receive ADT and RT are a vulnerable population with prevalent baseline cardiovascular disease and risk factors and suboptimal survivorship care specifically related to coordinated care and cardiovascular monitoring. Clinical trials examining ways to improve the care and outcomes of these survivors are needed.
引用
- Holmes JA, Anderson RF, Hoffman LG, et al. Cardiovascular Preventive Care and Coordination of Care in Prostate Cancer Survivors: A Multi-Institutional Prospective Study. Int J Radiat Oncol Biol Phys. 2018. PMID: 30099132. doi:10.1016/j.ijrobp.2018.07.2018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。